Gloréau Biotech Group Partners with Giant Medical to Enter Vietnam, Expanding Southeast Asian Healthcare Market

Gloréau Biotech Holdings (6431) has partnered with Taiwan medical aesthetics equipment provider Giant Medical Technology to jointly participate in 'Vietbeauty & Cosmobeauté Vietnam 2026,' held from July 23 to 25 in Ho Chi Minh City, Vietnam. The collaboration integrates medical aesthetics devices, clinical-grade skincare, and clinic services, demonstrating Taiwan's healthcare industry's strategic evolution from product exports to integrated service solutions on the global stage.

This exhibition features Gloréau Biotech Group integrating resources across its ecosystem, combining the clinical service expertise of its subsidiary Chen-Yao International Medical System, Giant Medical’s medical aesthetics device technology, and clinical-grade skincare products from Gloréau Group’s biotech brands. Together, they have built a one-stop integrated model encompassing medical devices, treatment applications, professional care, home care, and local support—offering overseas partners a more comprehensive healthcare solution.

Wang Chia-wei, Chairman of Taiwan Gloréau Industrial Co., Ltd., stated that Vietnam is a key strategic hub for the group’s Southeast Asian expansion. The company has already established an office in Hanoi, serving as a base for market development, channel partnerships, and local services. This joint participation with Giant Medical not only strengthens connectivity across Vietnam’s northern and southern markets but also marks a significant milestone in Taiwan’s healthcare industry transitioning from product supply to integrated service exports.

Wang noted that Gloréau Biotech Group has long been committed to integrating medical, biotech, and health management resources. This partnership with Giant Medical goes beyond co-exhibiting—it aims to link Taiwan’s medical equipment, biotech skincare, clinic operations, and local service capabilities to build a complete integrated service model. Moving forward, the group will leverage its Hanoi office as a foundation and collaborate with Giant Medical’s presence in Ho Chi Minh City to deepen local channel and clinic partnerships, gradually establishing an operational model replicable across other Southeast Asian markets.

The Gloréau Centella Soothing & Repair Series—clinical-grade skincare products manufactured by Shanghai Yidai, a subsidiary of Gloréau Group—will be paired with medical aesthetics devices and technical support from Giant Medical to construct an integrated service model covering medical devices, treatment protocols, professional care, home care, and local services. Unlike traditional single-device or skincare product sales, this model emphasizes synergistic application of treatments and skincare regimens, extending post-device skin care and product demand. This enhances partner clinics’ service completeness, customer retention, and operational efficiency.

At the exhibition, Giant Medical will showcase its E20 Low-Temperature Plasma device, D12 IPL Pulse Light device, and M10 Multi-Functional Platform, covering low-temperature plasma, pulse light, and multi-functional treatment platforms—offering diverse applications tailored to clinic size and treatment needs. Meanwhile, Gloréau Group will present its Gloréau Centella Repair Series professional skincare products, fully demonstrating an integrated health service model that extends from in-clinic treatments to at-home care.

Going forward, Gloréau Biotech Group will continue deepening its Southeast Asian market presence, integrating its medical, biotech, health management, and international distribution resources. By collaborating with more domestic and international partners, the group aims to promote Taiwan’s healthcare services globally, building replicable and scalable integrated operational models to continuously enhance the competitiveness and influence of Taiwan’s healthcare brands in international markets.